Franklin Biolabs is a fully integrated contract research organization accelerating the global development of transformative advanced therapies from discovery to commercialization. Our GLP and non-GLP capabilities include AAV vector production, analytical testing, preclinical studies, in vivo studies (e.g., rodents, non-human primates), pharmacology and toxicology assessments, pathology, immunology, and bioanalytical services, ensuring a seamless path from research to regulatory approval.